中順潔柔(002511.SZ):擬使用不超6億元自有閒置資金購買理財產品
格隆匯11月22日丨中順潔柔(002511.SZ)公佈,2022年11月22日,公司分別召開第五屆董事會第十七次會議及第五屆監事會第十二次會議,審議通過了《關於2023年使用自有閒置資金購買理財產品的議案》,在保障公司正常生產經營資金需求的情況下,為優化資金配置,提高自有閒置資金的使用效率和收益,公司及下屬公司擬使用不超過6億元人民幣的自有閒置資金購買低風險、短期(不超1年,含1年)的理財產品。在上述額度內,資金可以滾動使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.